SFKKA9031U Intellectual Property Rights and Innovation in Pharmaceutical Sciences

Volume 2013/2014
Education
MSc in Pharmaceutical Sciences - elective, MSc in Medicinal Chemistry - elective, Cand.Scient.Pharm. - elective, Cand.Pharm. - elective
Content
The course will start by introducing the conditions for discovery, intellectual property rights and patenting, with the drug field in mind. The structure of a patent application will be reviewed and concepts such as objective novelty, priority principle and inventive step will be reviewed and illustrated with examples. Emphasis will be on principles and strategies in connection with preparing patent applications, with weight on types of requirements and their formulation. Various illustrative case stories will be reviewed and worked on in groups, and students will then present their results. Conditions regarding intellectual property rights and infringements will be reviewed. An account will be made of various aspects of patent literature as well as approaches to and searches of this area in pharmaceutical literature. During the course students will increasingly be asked to work in groups on the topics covered. For project work, students will work in groups of 3 to 4 around given patent files. Project work will be presented during project presentation.
Learning Outcome

Formål / Objective

To give participants an overview of the significance of intellectual property rights (IPR) on pharmaceutical research and development generally and the pharmaceutical industry in particular. Participants will learn why an active drug-IPR strategy is necessary for a company in order to earn back its huge investments in research and development, as well as to maintain its core business without infringing on the intellectual property rights of other companies. Participants will gain understanding of why it is important for the company’s IPR policy to have a positive contagious effect and for everyone - regardless of what function in a pharmaceutical company a pharmacist has - to be alert to identifying patentable opportunities for the company. Participants also learn why it is important for research institutes, including institutions of higher education and sector research departments, to protect the new developments/discoveries made. Participants will be introduced to several innovative business case studies.

Målbeskrivelse / Course outcome

At the end of the course, students should:
  • Understand the basic principles of intellectual property rights and international patenting systems
  • Understand the importance of an active intellectual property rights policy in the pharmaceutical area
  • Be able to identify innovative elements of a given pharmaceutical case and its relationship to intellectual property rights
  • Have insight into the significance of evaluating the dominance and infringement situation prior to marketing a new drug, for example
  • Have acquired skills in reading and interpreting a patent application and a patent
  • Have acquired skills in applying the general principles on which a patent application is prepared, regardless of whether one is conducting drug research at an institution of higher education or a drug company.
Literature
Review articles, patent applications and supplementary notes available from the course homepage
Students are expected to have a relevant background (e.g., from the pharmaceutical, life or health sciences) and a special interest in the pharmaceutical field.
•Lectures: 40 hours
•Seminar: 4 hours, including student presentation and discussion
  • Category
  • Hours
  • Colloquia
  • 7
  • Lectures
  • 40
  • Preparation
  • 102
  • Project work
  • 60
  • Total
  • 209
Credit
7,5 ECTS
Type of assessment
Course participation
Satisfactory participation during the lectures, project work and seminar
Marking scale
passed/not passed
Censorship form
No external censorship
Criteria for exam assesment
Satisfactory participation during the lectures, project work and seminar